![全球援助儀式分析報(bào)告-培訓(xùn)課件外文版2024.5_第1頁(yè)](http://file4.renrendoc.com/view4/M02/0B/17/wKhkGGZ_vMmAQRn4AABiKTVrUwE032.jpg)
![全球援助儀式分析報(bào)告-培訓(xùn)課件外文版2024.5_第2頁(yè)](http://file4.renrendoc.com/view4/M02/0B/17/wKhkGGZ_vMmAQRn4AABiKTVrUwE0322.jpg)
![全球援助儀式分析報(bào)告-培訓(xùn)課件外文版2024.5_第3頁(yè)](http://file4.renrendoc.com/view4/M02/0B/17/wKhkGGZ_vMmAQRn4AABiKTVrUwE0323.jpg)
![全球援助儀式分析報(bào)告-培訓(xùn)課件外文版2024.5_第4頁(yè)](http://file4.renrendoc.com/view4/M02/0B/17/wKhkGGZ_vMmAQRn4AABiKTVrUwE0324.jpg)
![全球援助儀式分析報(bào)告-培訓(xùn)課件外文版2024.5_第5頁(yè)](http://file4.renrendoc.com/view4/M02/0B/17/wKhkGGZ_vMmAQRn4AABiKTVrUwE0325.jpg)
版權(quán)說(shuō)明:本文檔由用戶(hù)提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
COMPANIES
&
PRODUCTSRiteAidCHAPTER
01MarketoverviewRevenueofthepharmaciesanddrugstoresindustryintheUnitedStatesfrom2009to2022(inbillionU.S.dollars)Revenueofthepharmacies&drugstoresindustryintheU.S.2009-2022400350351.6338.2318.86312.61303.45296.96289.8230025020015010050283.92272.88266.14261.1259.67261.4258.240200920102011201220132014201520162017201820192020202120223Description:TherevenueoftheU.S.pharmaciesanddrugstoresindustrywasestimatedtovalueabout318.86billionU.S.dollarsin2020.Theindustrywasprojectedtoreachavalueof351.6billionU.S.dollarsby2022.
ReadmoreNote(s):UnitedStates;2022Source(s):IBISWorldAverageannualexpenditureonprescriptiondrugsperconsumerunitintheUnitedStatesfrom2007to2022(inU.S.dollars)U.S.householdexpenditureonprescriptiondrugs2007-2022400366.4361.72359.32355.73350.07344.56341.3835030025020015010050329.67321.55296.04285.67
284.69269.85267.69263.18259.19020072008200920102011201220132014201520162017201820192020202120224Description:ThisstatisticshowstheaverageannualexpenditureonprescriptiondrugsperconsumerunitintheUnitedStatesfrom2007to2022.In2022,thecountry'saverageexpenditureonprescriptiondrugsamountedtosome341U.S.dollarsperconsumerunit,anincreaseofmorethan70dollarscomparedtothepreviousyear.ReadmoreNote(s):UnitedStatesSource(s):BureauofLaborStatisticsPharmacyanddrugstoresalesintheUnitedStatesfrom1992to2021(inbillionU.S.dollars)PharmacyanddrugstoresalesintheU.S.1992-2021350300250200150100501992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021Year5Description:ThistimelinedepictspharmacyanddrugstoresalesintheUnitedStatesfrom1992to2021.In2021,U.S.pharmacyanddrugstoresalesamountedtoabout324.6billionU.S.dollars.
ReadmoreNote(s):UnitedStates;1992to2021Source(s):USCensusBureauAverageannualexpenditureonnonprescriptiondrugsperconsumerunitintheUnitedStatesfrom2007to2022(inU.S.dollars)U.S.householdexpenditureonnonprescriptiondrugs2007-2022155145135142.43133.7125.4412511510595120.9120.02115.74111.6799.6699.5797.49201296.26201392.57201189.56201086.62200881.7420098575.4756520072014201520162017201820192020202120226Description:ThisstatisticshowstheaverageannualexpenditureonnonprescriptiondrugsperconsumerunitintheUnitedStatesfrom2007to2022.In2022,thecountry'saverageexpenditureonnonprescriptiondrugsamountedtoover140U.S.dollarsperconsumerunit.ReadmoreNote(s):UnitedStates;2007to2022Source(s):BureauofLaborStatisticsConsumerpriceindexforprescriptionandnonprescriptiondrugsintheU.S.from1960to2022U.S.consumerpriceindex:prescriptionandnonprescriptiondrugs1960-2022PrescriptiondrugsNonprescriptiondrugs*469.8600537.9534.9525.4
522.1525.2
525.3511.2481.1500441.6437.9429.8412.8396.5379.94003002001000369.2156.8349285.4235181.7120.6149.5
151.7140.51009999.1
99.7
98.4
98.39797.2
96.8
97.396.8
10296.595.972.55447.41960
1970
1980
1990
1995
2000
2005
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
20227/statistics/187253/us-consumer-price-index-for-prescription-drugs-from-1960AsofDecember2022,theCPIforprescriptiondrugswasat535comparedtotheperiodfrom1982to1984(=100).ThisstatisticshowstheconsumerpriceindexforprescriptionandnonprescriptiondrugsintheUnitedStatesfrom1960to2022.
ReadmoreNote(s):UnitedStatesSource(s):BureauofLaborStatistics;USDepartmentofLaborCHAPTER
02MainplayersLeadingpharmaciesintheUnitedStatesin2022,basedonprescriptionrevenue(inbillionU.S.dollars)LeadingpharmaciesintheU.S.2022,basedonprescriptionrevenueRevenueinbillionU.S.dollars020406080100120140160CVSHealthCorporation*WalgreensBootsAllianceCigna(Evernorth/ExpressScripts)UnitedHealthGroup(OptumRx)WalmartStores,Inc.**TheKrogerCompanyRiteAidCorporation140.185.261.337.824.116.812.9Humana(CenterWell)AlbertsonsCompaniesPublix9.76.46.1CostcoWholesaleCorporationBrightSpringHealthServicesCentene(EnvolveHealth)AholdDelhaize32.82.72.72.4CarepathRx9Description:ThisstatisticshowstheleadingpharmaciesintheUnitedStatesin2022,basedonprescriptionrevenue.Inthatyear,CVSHealthCorporation'sprescriptionrevenueintheUnitedStatesamountedtoanestimated140billionU.S.dollars.
ReadmoreNote(s):UnitedStates;*Retailpharmacyprescriptionrevenue81.1billionU.S.dollars;Pharmacyservicesrevenue59billionU.S.dollars.**IncludesWalmartandSam'sClubstores.
ReadmoreSource(s):DrugChannelsInstituteTopU.S.pharmaciesrankedbyprescriptiondrugsmarketsharein2022U.S.pharmaciesrankedbyprescriptiondrugsmarketshare2022Marketshare0%5%10%15%20%25%30%CVShealthCorporation*WalgreensBootsAlliance(RetailPharmacyUSA)Cigna(Evernorth/ExpressScripts,Inc.)**UnitedHealthGroup(OptumRx)WalmartStores,Inc.25.6%15.5%11.2%6.9%4.4%TheKrogerCompanyRiteAidCorporationHumana(CenterWell)AlbertsonsCompanies3.1%2.3%1.8%1.2%1.1%0.6%PublixCostcoWholesaleCorporationBrightSpringHealthServicesCentene(EnvolveHealth)AholdDelhaize0.5%0.5%0.5%0.4%CarepathRx10Description:ThetopU.S.pharmacyin2022bymarketsharebasedonprescriptiondrugrevenuewasCVSHealthCorporation,followedbyWalgreensBootsAlliance.CVSHealthheldover25percentoftheprescriptiondrugmarketrevenueatthattime.AsignificantincreaseinmarketsharewasreportedforCignaachievedthroughtheacquisitionofpharmacybenefitmanagerExpressScriptsinAugust2018.Beforethat,Cignawasmainlyactiveintheinsurancebusinessandrelatedproductsand[...]
ReadmoreNote(s):UnitedStatesSource(s):DrugChannelsInstituteLeadingdrugstoresintheUnitedStatesin2022,basedonretailsales(inbillionU.S.dollars)LeadingdrugstoresintheU.S.2022,basedonretailsalesRetailsalesinbillionU.S.dollars40
6002080100120140WalgreensBootAllianceCVSHealthCorporationRiteAid116.1106.5917.57Hy-Vee12.44HealthMartSystems11.911Description:ThisrankingshowstheleadingdrugstoresintheUnitedStates,basedonworldwideretailsalesintheyearof2022.Inthatyear,WalgreensBootAlliancewastheleadingdrugstoreintheUnitedStateswithretailsalesaddinguptoabout116billionU.S.dollars.ReadmoreNote(s):UnitedStates;2023Source(s):Kantar;NationalRetailFederationNumberofstoresoftheleadingdrugstoresintheUnitedStatesin2022NumberofstoresoftheleadingdrugstoresintheU.S.202212,0009,72810,0008,0006,0004,0002,00008,7855,3264,7342,8562,3502,309574371329CVSHealthWalgreensBootsAllianceWalmartHealthMart
TheKrogerCo.Good
NeighborSystem
PharmacyCompanyRiteAidCostcoWakefern/ShopRiteHy-Vee12Description:ThisstatisticshowsthenumberofstoresoftheleadingdrugstoresintheUnitedStatesin2022,byformat.Inthatyear,RiteAidhadatotalof2,309storesintheUnitedStates.ReadmoreNote(s):UnitedStates;2022Source(s):NationalRetailFederationLeadingonlinepharmaciesrankedbybrandawarenessintheUnitedStatesin2022Mostwell-knownonlinepharmaciesintheUnitedStates2022Shareofrespondents40%
50%0%10%20%30%60%70%80%90%100%WalgreensCVSpharmacy88%86%RiteAid77%HealthWAllegroMedicalNorthWestPCanadaPInstaflex20%18%16%16%15%CanadaPharmacyOnlineLloydsPharmacy15%15%15%CanadianPharmacyWorldMEDICALMEGA14%14%13Description:With88%brandawarenessisWalgreensthemostpopularonlinepharmacyintheU.S.SecondonthislistisCVSpharmacywhichisrecognizedby84%ofinternetrespondentsintheUnitedStates,followedbyanother77%consumerswhoareawareofRiteAid.Hcomesinfourthonthislist,followedbyAllegroMedicalandNorthWestP.ReadmoreNote(s):UnitedStates;JunetoJuly2022;1244respondents;18to64yearsSource(s):ConsumerInsightsLeadingbeautyandhealthonlineshopsrankedbybrandawarenessintheUnitedStatesin2022Mostwell-knownbeautyandhealthonlineshopsintheUnitedStates2022Shareofrespondents0%10%20%30%40%50%60%70%80%90%100%WalgreensCVS89%89%Bath&BodyWorksRiteAid85%76%Sephora71%ULTA67%MacCosmeticsTheBodyShopIPSY48%47%43%42%42%BirchboxAmwayMorpheFragranceNet32%31%14Description:With89%each,WalgreensandCVSaretwoofthemostwell-knownbeautyandhealthonlineshopsintheU.S.AnotherAmericanbrand,Bath&BodyWorks,comesthirdinthislistasitisrecognizedby85%ofinternetrespondents.RiteAidclaimsthefourthspotfollowedbySephoraandULTA.ReadmoreNote(s):UnitedStates;JunetoJuly2022;1247respondents;18to64yearsSource(s):ConsumerInsightsCHAPTER
03KeyfiguresofRiteAidTotalrevenueofRiteAidCorporationintheUnitedStatesfrom2012to2023(inbillionU.S.dollars)RevenueoftheRiteAidCorporationintheU.S.2012-20233026.5326.1225.3925.5324.5724.0424.0925201510522.9321.9321.5321.6420.77020122013201420152016*2017*2018*2019*202020212022202316Description:ThisstatisticshowsthetotalrevenueoftheRiteAidCorporationintheUnitedStatesfrom2012to2023.In2023,RiteAidgeneratedabout24.09billionU.S.dollarsintotalrevenue.ReadmoreNote(s):UnitedStates;2012to2023;*Revenuesforthefiscalyearsended.February27,2021,February29,2020,March2,2019,March3,2018,March4,2017andFebruary27,2016exclude$200,326,$232,964and$153,664,respectively,of[...]
ReadmoreSource(s):RiteAidTotalrevenueofRiteAidCorporationintheUnitedStatesfromfiscalyear2017to2023,bysegment(inbillionU.S.dollars)U.S.revenueofRiteAidfrom2017to2023bysegmentRetailpharmacyPharmacyservicesIntersegmenteliminations*302520151057.3217.56.527.976.395.96.096.617.7916.7716.3615.8315.7615.620-0.232017-0.2-0.212019-0.252020-0.292021-0.252022-0.222023-5201817/statistics/1004217/revenue-of-rite-aid-by-segmentThisstatisticshowsthetotalrevenueofRiteAidCorporationintheUnitedStatesfrom2017to2023,brokendownbysegment.Inthefiscalyear2023,theretailpharmacysegmentofRiteAidgeneratednearly17.8billionU.S.dollarsintheUnitedStates.ReadmoreNote(s):UnitedStates;2017to2023;*IntersegmenteliminationsincludeintersegmentrevenuesandcorrespondingcostofrevenuesthatoccurwhenPharmacyServicessegmentcustomersuseRetailPharmacysegmentstorestopurchase[...]
ReadmoreSource(s):RiteAidTotalrevenuegrowthofRiteAidCorporationintheUnitedStatesfrom2014to2023(inbillionU.S.dollars)RevenuegrowthoftheRiteAidCorporationintheU.S.2014-202330%25.4%25%20%15%10.4%9.6%10%3.9%20155%0%2.2%20221.3%20200.5%20140.5%2019-1.9%2023-5%-6.1%2018-10%20162017202118Description:ThisstatisticshowsthetotalrevenuegrowthoftheRiteAidCorporationintheUnitedStatesfrom2014to2023.Inthefinancialyear2023whichendedonMarch4,2023,thecompany'srevenuedeclinedby1.9percent.
ReadmoreNote(s):UnitedStates;2014to2023Source(s):RiteAidTotalrevenueofRiteAidCorporationintheUnitedStatesin2023,byquarter(inbillionU.S.dollars)U.S.revenueofRiteAid2023,byquarter76.086.096.015.96543210Q1Q2Q3Q419Description:ThisstatisticshowsthetotalrevenueofRiteAidCorporationintheUnitedStatesforthefiscalyear2023,byquarter.RiteAidgeneratedabout6.09billionU.S.dollarsinthefourthquarterof2023.ReadmoreNote(s):UnitedStates;2023Source(s):RiteAidGrossprofitofRiteAidCorporationintheUnitedStatesfrom2018to2023(inmillionU.S.dollars)GrossprofitoftheRiteAidCorporationintheU.S.2018-20236,0005,106.55,0004,0003,0002,0001,00004,780.14,726.764,803.944,676.354,704.3220182019202020212022202320Description:TheRiteAidCorporation'sgrossprofitintheUnitedStateswasabout4.8billionU.S.dollarsforthefiscalyearendedMarch4,2023.Thatyear,RiteAidgeneratedabout24.09billionU.S.dollarsintotalrevenue.
ReadmoreNote(s):UnitedStates;2018to2023Source(s):RiteAidSalesshareofRiteAidintheUnitedStatesin2023,byproductclassSalesshareofRiteAidintheU.S.2023,byproductclassHealthandbeautyaids4.3%Over-the-countermedicationsandpersonalcare10.9%Generalmerchandiseandother13.6%Prescriptiondrugs71.2%21Description:ThestatisticdepictsthesalesshareofRiteAidintheUnitedStatesinthefiscalyearendingMarch4,2023,byproductclass.Inthatyear,healthandbeautyaidproductsgeneratedoverfourpercentofRiteAid'ssales.
ReadmoreNote(s):UnitedStates;2023Source(s):RiteAidTotalnumberofstoresofRiteAidintheUnitedStatesfrom2012to2023TotalnumberofstoresofRiteAidintheU.S.2012-20235,0004,6674,6234,5874,5704,5614,5364,5004,0003,5003,0002,5002,0001,5001,0005002,5502,5102,4692,4612,4502,3090201220132014201520162017201820192020202120222023Year22Description:ThestatisticdepictsthetotalnumberofstoresofRiteAidintheUnitedStatesfrom2012to2023.In2023,RiteAidoperated2,309storesthroughouttheUnitedStates,downfrom4,623adecadeagoin2013.
ReadmoreNote(s):UnitedStates;2012to2023Source(s):RiteAidTotalnumberofstoresofRiteAidintheUnitedStatesin2023,bystateNumberofstoresofRiteAidintheU.S.2023,bystateNumberofstores050100150200250300350400450500550PennsylvaniaCaliforniaNewYorkMichigan487477271249Ohio195191WashingtonNewJerseyOregon112686458VirginiaNewHampshireMarylandDelawareConnecticut40373023Description:ThestatisticdepictsthetotalnumberofstoresofRiteAidintheUnitedStatesasofMarch4,2023,bystate.Inthatyear,RiteAidoperated64storesinVirginia.ReadmoreNote(s):UnitedStates;2023Source(s):RiteAidRiteAidbrandawareness,usage,popularity,loyalty,andbuzzamongbeautyandhealthonlineshopusersintheUnitedStatesin2022RiteAidbrandprofileintheUnitedStates202278%80%70%60%50%40%30%20%10%0%22%19%16%15%RiteAidawarenessRiteAidpopularityRiteAidusageRiteAidloyaltyRiteAidbuzz24Description:HowhighisthebrandawarenessofRiteAidintheUnitedStates?ReadmoreNote(s):UnitedStates;15June2022to23June2022;1039respondents;18-64years;respondentswhousebeauty&healthSource(s):ConsumerInsightsRiteAidbrandawareness,usage,popularity,loyalty,andbuzzamongonlinepharmacyusersintheUnitedStatesin2022RiteAidbrandprofileintheUnitedStates202280%80%70%60%50%40%30%20%10%0%36%27%23%21%RiteAidawarenessRiteAidpopularityRiteAidusageRiteAidloyaltyRiteAidbuzz25Description:HowhighisthebrandawarenessofRiteAidintheUnitedStates?ReadmoreNote(s):UnitedStates;15June2022to26July2022;885respondents;18-64years;respondentswhouseonlinepharmaciesSource(s):ConsumerInsightsCHAPTER
04CompetitorsCVSHealth'snetincomefrom2006to2022(inmillionU.S.dollars)CVSHealth'snetincome2006-20229,0008,0007,8987,1926,6236,6317,0006,0005,0004,0003,0002,0001,00005,3195,2374,5924,6444,1653,8643,6903,4243,4623,1982,6231,3552006-1,000-2,000-596200720082009201020112012201320142015201620172018201920202021202227Description:TheCVSHealthCorporationisaU.S.drugretailingcompany,withthreemajorsegments:CVS/pharmacy,CaremarkPharmacyServicesandMinuteClinic.CVSHealthisheadquarteredinWoonsocket,RhodeIsland.In2022,thecompany'snetincomewasrecordedatapproximately4.16billionU.S.dollars.In2014,thecompanychangeditsnamefromCVSCaremarktoCVSHealth.ReadmoreNote(s):UnitedStates;2006to2022Source(s):CVSHealthCVSHealth'srevenuefrom2005to2022(inmillionU.S.dollars)CVSHealth'srevenue2005-2022350,000300,000250,000200,000150,000100,00050,000020052006200720082009201020112012201320142015201620172018201920202021202228Description:Intheyear2022,theCVSHealthCorporationgeneratedapproximately322.5billionU.S.dollarsofrevenueintotal,anincreasecomparedtothepreviousyears.Thisvalueisthehighesteverregisteredintheconsideredtimeframe.
ReadmoreNote(s):UnitedStates;2005to2022Source(s):CVSHealthSalesofWalgreensBootsAllianceworldwidefrom2018to2023,bygeographicalregion(inmillionU.S.dollars)WalgreensBootsAlliancesalesworldwide2018-2023,bygeographicalregionUnitedStatesUnitedKingdomGermany**Other140,000120,000100,00080,00060,00040,00020,000020182019202020212022202329Description:WalgreensBootsAllianceisaUnitedStates-basedpharmacyretailandwholesalecompany,operatingpharmaciesanddrugstores.ThecompanygeneratesagreateramountofitstotalsalesfromtheUnitedStates,withsalesreachingmorethan116billionU.S.dollarsinthisregionin2023.InGermany,thevalueofWalgreens'ssaleswasrecordedasapproximately11.2billionU.S.dollarsin2023.ReadmoreNote(s):Worldwide;2018to2023Source(s):WalgreensRetailpharmacysalesofWalgreensintheUnitedStatesfrom2018to2023,bydivision(inmillionU.S.dollars)WalgreenspharmacyretailsalesintheU.S.2018-2023,bydivisionPharmacyRetail84,89290,00082,11880,48180,43477,19280,00070,00060,00050,00040,00030,00020,00010,000071,05528,64328,19527,33727,34027,22027,11320182019202020212022202330Description:Salesfromitspharmacysegme
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 物聯(lián)網(wǎng)技術(shù)在職教實(shí)訓(xùn)室的應(yīng)用前景
- 現(xiàn)代物流配送體系的智能化升級(jí)路徑
- 2024年學(xué)年八年級(jí)語(yǔ)文上冊(cè) 第一單元 愛(ài)在人間 第3課《蘆花蕩》說(shuō)課稿 滬教版五四制
- 2024年四年級(jí)英語(yǔ)下冊(cè) Unit 5 What will you do this weekend Lesson 25說(shuō)課稿 人教精通版(三起)
- Unit 1 Greetings(說(shuō)課稿)-2024-2025學(xué)年滬教版(五四制)(2024)英語(yǔ)一年級(jí)上冊(cè)
- 2023二年級(jí)數(shù)學(xué)下冊(cè) 7 萬(wàn)以?xún)?nèi)數(shù)的認(rèn)識(shí)第2課時(shí) 1000以?xún)?nèi)數(shù)的認(rèn)識(shí)(2)說(shuō)課稿 新人教版
- Unit 3 Food Let's Spell(說(shuō)課稿)-2024-2025學(xué)年人教新起點(diǎn)版英語(yǔ)三年級(jí)上冊(cè)
- 2024-2025學(xué)年高一地理《宇宙中的地球》說(shuō)課稿
- 2023六年級(jí)數(shù)學(xué)上冊(cè) 八 探索樂(lè)園單元概述和課時(shí)安排說(shuō)課稿 冀教版
- 2024-2025學(xué)年高中歷史 專(zhuān)題4 雅爾塔體制下的冷戰(zhàn)與和平 3 人類(lèi)對(duì)和平的追求說(shuō)課稿(含解析)人民版選修3
- GA/T 1133-2014基于視頻圖像的車(chē)輛行駛速度技術(shù)鑒定
- GB∕T 41461-2022 自助銀行網(wǎng)點(diǎn)服務(wù)要求
- 學(xué)校委托管理協(xié)議書(shū)范本
- 重醫(yī)大《護(hù)理學(xué)導(dǎo)論》期末試卷(兩套)及答案
- 部編新教材人教版七年級(jí)上冊(cè)歷史重要知識(shí)點(diǎn)歸納
- 重點(diǎn)時(shí)段及節(jié)假日前安全檢查表
- 建筑樁基技術(shù)規(guī)范2018年
- 物理調(diào)查問(wèn)卷
- 給排水管道工程分項(xiàng)、分部、單位工程劃分
- 《傻子上學(xué)》臺(tái)詞
- 高中英語(yǔ)新課程標(biāo)準(zhǔn)解讀 (課堂PPT)
評(píng)論
0/150
提交評(píng)論